This was announced to La Stampa by Marco Cavaleri, head of the EMA's Health Threats and Vaccination Strategy.
“We have completed inspections of facilities and are awaiting the missing information,” TASS quotes him.
Cavalieri found it difficult to name the timing of the review of the dossier for the approval of the Russian drug.
At the same time, he added that "for approval, the EMA will rely only on the ratio of risk and benefit."
Earlier, the Minister for Foreign and European Affairs of Malta, Evarist Bartolo, said that the EMA could register the Russian Sputnik V vaccine by the end of June.
On May 12, EMA spoke about the possible time frame for the approval of the Sputnik V vaccine.
At the end of April, it was reported that EMA had completed the first stage of the examination of the Russian Sputnik V coronavirus vaccine.